Two Faces of Arbutine in Hepatocelluler Carcinoma (HepG2) Cells: Anticarcinogenic Effect in LD50 Dose and Protective Effect Against Cisplatin Toxication Through its Antioxidant and Anti-Inflammatory Activity in LD0 Dose
Research Square (Research Square)